Interestingly, melatonin has limited inhibitory effects on androgen-independent prostate cancer cell lines PC-3 or DU145, possibly because the antiproliferative ability of MLT/MT1 depends on the activation of androgen/AR in prostate cancer cells (Siu et al., 2002). The gene discussed is AR; the disease is prostate carcinoma.